{
  "ticker": "LH",
  "year": 2022,
  "quarter": 3,
  "last_updated": "2025-04-15T15:30:14.989776",
  "count": 20,
  "transactions": [
    {
      "id": 12585,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-09-26",
      "transaction_shares": "5627",
      "transaction_price": "209.294",
      "transaction_type": "S",
      "shares_after_transaction": "46531"
    },
    {
      "id": 28663,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-09-26",
      "transaction_shares": "5627",
      "transaction_price": "209.294",
      "transaction_type": "S",
      "shares_after_transaction": "46531"
    },
    {
      "id": 53874,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-09-26",
      "transaction_shares": "5627",
      "transaction_price": "209.294",
      "transaction_type": "S",
      "shares_after_transaction": "46531"
    },
    {
      "id": 90080,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-09-26",
      "transaction_shares": "5627",
      "transaction_price": "209.294",
      "transaction_type": "S",
      "shares_after_transaction": "46531"
    },
    {
      "id": 133781,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-09-26",
      "transaction_shares": "5627",
      "transaction_price": "209.294",
      "transaction_type": "S",
      "shares_after_transaction": "46531"
    },
    {
      "id": 12587,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-09-07",
      "transaction_shares": "44.338",
      "transaction_price": "231.2003",
      "transaction_type": "P",
      "shares_after_transaction": "14281.78"
    },
    {
      "id": 28665,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-09-07",
      "transaction_shares": "44.338",
      "transaction_price": "231.2003",
      "transaction_type": "P",
      "shares_after_transaction": "14281.78"
    },
    {
      "id": 53905,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-09-07",
      "transaction_shares": "44.338",
      "transaction_price": "231.2003",
      "transaction_type": "P",
      "shares_after_transaction": "14281.78"
    },
    {
      "id": 90118,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-09-07",
      "transaction_shares": "44.338",
      "transaction_price": "231.2003",
      "transaction_type": "P",
      "shares_after_transaction": "14281.78"
    },
    {
      "id": 133820,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Caveney Brian J",
      "reporting_owner_cik": "0001717915",
      "reporting_owner_position": "EVP, President of Diagnostics",
      "transaction_date": "2022-09-07",
      "transaction_shares": "44.338",
      "transaction_price": "231.2003",
      "transaction_type": "P",
      "shares_after_transaction": "14281.78"
    },
    {
      "id": 12589,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-08-03",
      "transaction_shares": "11400",
      "transaction_price": "130.60",
      "transaction_type": "M",
      "shares_after_transaction": "63558"
    },
    {
      "id": 28668,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-08-03",
      "transaction_shares": "11400",
      "transaction_price": "130.60",
      "transaction_type": "M",
      "shares_after_transaction": "63558"
    },
    {
      "id": 53912,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-08-03",
      "transaction_shares": "11400",
      "transaction_price": "130.60",
      "transaction_type": "M",
      "shares_after_transaction": "63558"
    },
    {
      "id": 90126,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-08-03",
      "transaction_shares": "11400",
      "transaction_price": "130.60",
      "transaction_type": "M",
      "shares_after_transaction": "63558"
    },
    {
      "id": 133829,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "EISENBERG GLENN A",
      "reporting_owner_cik": "0001222831",
      "reporting_owner_position": "Chief Financial Officer, EVP",
      "transaction_date": "2022-08-03",
      "transaction_shares": "11400",
      "transaction_price": "130.60",
      "transaction_type": "M",
      "shares_after_transaction": "63558"
    },
    {
      "id": 12588,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1809",
      "transaction_price": "258.3125",
      "transaction_type": "S",
      "shares_after_transaction": "1887.2194"
    },
    {
      "id": 28666,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1809",
      "transaction_price": "258.3125",
      "transaction_type": "S",
      "shares_after_transaction": "1887.2194"
    },
    {
      "id": 53906,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1809",
      "transaction_price": "258.3125",
      "transaction_type": "S",
      "shares_after_transaction": "1887.2194"
    },
    {
      "id": 90119,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1809",
      "transaction_price": "258.3125",
      "transaction_type": "S",
      "shares_after_transaction": "1887.2194"
    },
    {
      "id": 133821,
      "issuer_name": "LABORATORY CORP OF AMERICA HOLDINGS",
      "reporting_owner": "Wilkinson Peter J",
      "reporting_owner_cik": "0001398138",
      "reporting_owner_position": "SVP, Chief Accounting Officer",
      "transaction_date": "2022-08-01",
      "transaction_shares": "1809",
      "transaction_price": "258.3125",
      "transaction_type": "S",
      "shares_after_transaction": "1887.2194"
    }
  ]
}